AR029403A1 - Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento - Google Patents

Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento

Info

Publication number
AR029403A1
AR029403A1 ARP000105739A ARP000105739A AR029403A1 AR 029403 A1 AR029403 A1 AR 029403A1 AR P000105739 A ARP000105739 A AR P000105739A AR P000105739 A ARP000105739 A AR P000105739A AR 029403 A1 AR029403 A1 AR 029403A1
Authority
AR
Argentina
Prior art keywords
manufacture
preparation
carbamoiloxialquil
azolio
pharmaceutical composition
Prior art date
Application number
ARP000105739A
Other languages
English (en)
Spanish (es)
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of AR029403A1 publication Critical patent/AR029403A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ARP000105739A 1999-11-02 2000-10-31 Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento AR029403A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99121694 1999-11-02

Publications (1)

Publication Number Publication Date
AR029403A1 true AR029403A1 (es) 2003-06-25

Family

ID=8239312

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105739A AR029403A1 (es) 1999-11-02 2000-10-31 Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento

Country Status (22)

Country Link
EP (1) EP1280795B1 (en:Method)
JP (1) JP3787307B2 (en:Method)
KR (1) KR100449797B1 (en:Method)
CN (1) CN1185230C (en:Method)
AR (1) AR029403A1 (en:Method)
AT (1) ATE291575T1 (en:Method)
AU (1) AU777859B2 (en:Method)
BE (1) BE2016C007I2 (en:Method)
BR (1) BRPI0015254C1 (en:Method)
CA (2) CA2680292C (en:Method)
CY (1) CY2016002I1 (en:Method)
DE (1) DE60018989T2 (en:Method)
DK (1) DK1280795T3 (en:Method)
ES (1) ES2238341T3 (en:Method)
FR (1) FR15C0096I2 (en:Method)
LU (1) LU92939I2 (en:Method)
MX (1) MXPA02004145A (en:Method)
NL (1) NL300791I1 (en:Method)
PT (1) PT1280795E (en:Method)
TR (1) TR200201205T2 (en:Method)
WO (1) WO2001032652A2 (en:Method)
ZA (1) ZA200203003B (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
BRPI0815595B8 (pt) 2007-08-21 2021-05-25 Basilea Pharmaceutica Ag composição antifúngica para administração oral, que é autoemulsificante em contato com uma fase aquosa, seu uso e produto farmacêutico
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
BR112015030501A2 (pt) 2013-06-04 2017-07-25 Vyome Biosciences Pvt Ltd partículas revestidas e composições que compreendem as mesmas
CN104230894B (zh) * 2013-06-06 2016-08-24 南京华威医药科技开发有限公司 三唑类化合物
CN107207414B (zh) * 2014-12-30 2021-03-30 美国陶氏益农公司 具有杀真菌活性的吡啶酰胺化合物
CN106032356B (zh) * 2015-03-13 2018-09-14 江苏正大丰海制药有限公司 一种[n-甲基-吡啶-2-基]氨基甲酸-1-氯乙酯的制备方法
CN104974143A (zh) * 2015-05-12 2015-10-14 深圳致君制药有限公司 一种季铵盐类化合物、其制备方法以及用途
CN106467519B (zh) * 2015-08-17 2019-08-13 南京华威医药科技集团有限公司 一种水溶性三唑化合物
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN106565699B (zh) * 2015-10-10 2019-07-26 江苏正大丰海制药有限公司 一种艾沙康唑硫酸盐晶体及其制备方法
US10683387B2 (en) 2016-10-04 2020-06-16 Massachusetts Institute Of Technology Bottlebrush copolymers and uses thereof
WO2018149359A1 (zh) * 2017-02-17 2018-08-23 武汉朗来科技发展有限公司 三氮唑抗菌衍生物、其药物组合物和用途
CN106916152B (zh) * 2017-04-27 2019-09-17 扬子江药业集团有限公司 氧化还原反应制备艾沙康唑鎓单硫酸盐的方法
WO2019006426A2 (en) 2017-06-30 2019-01-03 Massachusetts Institute Of Technology RAMIFIED MULTIFUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF
US11752221B2 (en) 2017-06-30 2023-09-12 Massachusetts Institute Of Technology Brush-arm star polymer imaging agents and uses thereof
US10368502B2 (en) 2017-09-25 2019-08-06 Multiple Energy Technologies Llc Bioceramic and carbon-based hydroponic systems, methods and devices
CN110317165A (zh) * 2018-03-28 2019-10-11 上海医药工业研究院 一种药物中间体2-甲胺基-3-吡啶甲醇的制备方法
CN110551064B (zh) * 2018-06-01 2021-01-01 重庆世森医药科技有限公司 艾沙康唑硫酸酯及其中间体的制备方法
EP3830084B1 (en) 2018-08-01 2025-08-06 Basilea Pharmaceutica International AG, Allschwil Methods for purifying isavuconazonium sulfate
EP3837266A1 (en) 2018-08-17 2021-06-23 Massachusetts Institute of Technology Degradable polymers of a cyclic silyl ether and uses thereof
CN110128420A (zh) * 2019-05-08 2019-08-16 阴启明 硫酸氢根/硫酸根型阴离子交换技术制备艾沙康唑鎓单硫酸盐的方法
US20220289735A1 (en) 2019-08-26 2022-09-15 Synthon B.V. Isavuconazonium salts and process for preparing thereof
EP4045562A2 (en) * 2019-10-16 2022-08-24 Massachusetts Institute of Technology Brush prodrugs and uses thereof
US12042513B2 (en) 2020-01-10 2024-07-23 Massachusetts Institute Of Technology Proteolysis targeting chimeric molecules (PROTACs) with functional handles and uses thereof
JP7454905B2 (ja) * 2021-09-28 2024-03-25 旭化成ファーマ株式会社 有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び/又は予防剤
JP7570382B2 (ja) 2021-09-28 2024-10-21 旭化成ファーマ株式会社 エアベント付き輸液フィルタを備える点滴静脈投与用輸液セット
WO2023121753A1 (en) 2021-12-20 2023-06-29 Massachusetts Institute Of Technology Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent
EP4289840A1 (en) 2022-06-07 2023-12-13 Zaklady Farmaceutyczne Polpharma S.A. A process for preparing isavuconazonium sulfate
WO2024094329A1 (en) 2022-11-01 2024-05-10 Basilea Pharmaceutica International Ag, Allschwil Blister-packaged capsule preparation containing isavuconazonium sulfate
WO2024189550A1 (en) * 2023-03-13 2024-09-19 Apitoria Pharma Private Limited Process for the preparation of isavuconazonium sulfate and its crystalline forms
WO2025114603A1 (en) 2023-11-30 2025-06-05 Basilea Pharmaceutica International Ag, Allschwil Pharmaceutical combinations for use in the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3108997B2 (ja) * 1997-03-31 2000-11-13 武田薬品工業株式会社 アゾール化合物、その製造法および用途
CN1251098A (zh) * 1997-03-31 2000-04-19 武田药品工业株式会社 吡咯化合物,其制备及其用途
AU2931399A (en) * 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity

Also Published As

Publication number Publication date
ES2238341T3 (es) 2005-09-01
AU777859B2 (en) 2004-11-04
DE60018989T2 (de) 2005-08-18
MXPA02004145A (es) 2002-10-17
JP3787307B2 (ja) 2006-06-21
KR100449797B1 (ko) 2004-09-30
TR200201205T2 (tr) 2002-08-21
CA2388320C (en) 2009-12-15
WO2001032652A2 (en) 2001-05-10
KR20020062298A (ko) 2002-07-25
EP1280795B1 (en) 2005-03-23
BRPI0015254B8 (pt) 2017-04-25
FR15C0096I2 (fr) 2016-04-22
CN1387529A (zh) 2002-12-25
WO2001032652A3 (en) 2001-11-15
CA2680292A1 (en) 2001-05-10
ATE291575T1 (de) 2005-04-15
DK1280795T3 (da) 2005-07-18
NL300791I2 (en:Method) 2016-03-15
NL300791I1 (en:Method) 2016-03-15
FR15C0096I1 (en:Method) 2016-02-12
ES2238341T9 (es) 2016-03-02
BR0015254A (pt) 2002-06-25
LU92939I2 (fr) 2016-03-07
CY2016002I2 (el) 2016-10-05
DE60018989D1 (de) 2005-04-28
ZA200203003B (en) 2003-09-23
CA2388320A1 (en) 2001-05-10
CY2016002I1 (el) 2016-10-05
CA2680292C (en) 2012-11-27
CN1185230C (zh) 2005-01-19
BRPI0015254C1 (pt) 2021-05-25
BE2016C007I2 (en:Method) 2019-10-23
BR0015254B1 (pt) 2013-05-21
AU2835201A (en) 2001-05-14
EP1280795A2 (en) 2003-02-05
JP2003513090A (ja) 2003-04-08
PT1280795E (pt) 2005-06-30

Similar Documents

Publication Publication Date Title
AR029403A1 (es) Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
ATE450533T1 (de) Carboxamidderivate
AR029463A1 (es) Pirrolidinas disustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento
MXPA05012573A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de cinasa.
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
SE9904738D0 (sv) Novel compounds
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
UY28510A1 (es) Compuestos quimicos
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
PA8606201A1 (es) DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
AR029210A1 (es) DERIVADOS DE N-(5-SULFAMOIL-1,3-TIAZOL-2-IL) ACETAMIDA, PROCEDIMIENTO PARA SU PREPARACIoN, COMPUESTOS INTERMEDIARIOS, COMPOSICIoN FARMACÉUTICA, Y EL USO DE DICHOS DERIVADOS PARA LA PRODUCCIoN DE MEDICAMENTOS
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
BR0012610A (pt) Novo derivado de difenilpiperidina
SE9901573D0 (sv) New compounds
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
AR041340A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
ES2177671T3 (es) Benzamida enterocinetica.
SE0401655D0 (sv) New compounds
BR0309668A (pt) Imidazolinilmetil aralquilsulfonamidas
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.

Legal Events

Date Code Title Description
FG Grant, registration